<SEC-DOCUMENT>0001213900-20-014568.txt : 20200610
<SEC-HEADER>0001213900-20-014568.hdr.sgml : 20200610
<ACCEPTANCE-DATETIME>20200610081522
ACCESSION NUMBER:		0001213900-20-014568
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20200609
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200610
DATE AS OF CHANGE:		20200610

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OptimizeRx Corp
		CENTRAL INDEX KEY:			0001448431
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		IRS NUMBER:				261265381
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38543
		FILM NUMBER:		20953573

	BUSINESS ADDRESS:	
		STREET 1:		400 WATER ST., STE. 200
		CITY:			ROCHESTER
		STATE:			MI
		ZIP:			48307
		BUSINESS PHONE:		248-651-6558

	MAIL ADDRESS:	
		STREET 1:		400 WATER ST., STE. 200
		CITY:			ROCHESTER
		STATE:			MI
		ZIP:			48307
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea122879-8k_optimizerx.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WASHINGTON,
D.C. 20549<BR></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORM
8-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CURRENT
REPORT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURSUANT
TO SECTION 13 OR 15(d) OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
SECURITIES EXCHANGE ACT OF 1934<BR>
<BR>
</B>Date of Report (Date of earliest event reported): June 9, 2020<BR>
<BR>
<U>OptimizeRx Corporation</U><BR>
(Exact name of registrant as specified in its charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">Nevada</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%"><FONT STYLE="text-decoration: none">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">001-38543</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%"><FONT STYLE="text-decoration: none">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">26-1265381</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction <BR>
of incorporation)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission
    File Number)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer<BR>
 Identification No.)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">400
    Water Street, Suite 200, Rochester, MI</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48307</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&rsquo;s
telephone number, including area code: <U>248.651.6568</U></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 50%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
        name or former address, if changed since last report)</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; width: 4%; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; width: 96%; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company&nbsp;&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; width: 32%; border-bottom: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title
    of each class</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; width: 32%; border-bottom: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trading
    symbol</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; width: 32%; border-bottom: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    of each exchange on which registered</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OPRX</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq
    Capital Market</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SECTION
8 &ndash; Other Events</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0%"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
                          8.01</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
                                         Events</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 9, 2020, we issued a press release announcing that we have finalized a new partnership that expands our digital communication
platform by more than 300 health systems and 75,000 healthcare providers that utilize market-leading EHRs Epic and Cerner. A copy
of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in Item 8.01 of this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed &ldquo;filed&rdquo; for
purposes of Section 18 of the Securities Exchange Act of 1934 (the &ldquo;Exchange Act&rdquo;) or otherwise subject to the liabilities
of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange
Act, except as expressly set forth by specific reference in such a filing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
9 &ndash; Financial Statements and Exhibits</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0%"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
                          9.01</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financial
                                         Statements and Exhibits</B></FONT></TD></TR></TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0%"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%">99.1</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 90%"><A HREF="ea122879ex99-1_optimizerx.htm">Press
release, dated June 9, 2020</A></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>OptimizeRx Corporation</B></FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ Douglas Baker</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Douglas Baker</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Chief Financial Officer</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Date June 10, 2020</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea122879ex99-1_optimizerx.htm
<DESCRIPTION>PRESS RELEASE, DATED JUNE 9, 2020
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>OptimizeRx
Digital Health Platform Adds More than 300 Epic and Cerner Health Systems </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none"><B>ROCHESTER,
Mich. &ndash; June 9, 2020 &ndash; </B>OptimizeRx Corp. (Nasdaq: OPRX), <FONT STYLE="background-color: white">a leading provider
of d</FONT>igital health solutions for life science companies, payers, providers, and patients, has finalized a new partnership
that expands its digital communication platform by more than 300 health systems and 75,000 healthcare providers that utilize market-leading
EHRs Epic and Cerner.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">Healthcare
providers within these health systems will now have instant access to real-time patient savings information via OptimizeRx&rsquo;s
cloud-based platform as they are evaluating and prescribing treatments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">Linked
to as much as $528 billion in avoidable healthcare costs annually, medication non-adherence is a focal point of healthcare industry
performance improvement efforts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">High
out-of-pocket prescription drug costs drives non-adherence even in good economic times. With 33% of Americans delaying treatment
due to cost in 2019, this percentage is likely to rise given the current COVID-19 related economic challenges. Increased price
transparency within the provider daily workflow is one area of improvement that can make a difference in treatment adherence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Especially
in these challenging times, patients need help with the cost of healthcare,&rdquo; commented Miriam Paramore, president of OptimizeRx.
&ldquo;Often patients cannot afford their medications and therefore never get them. We are focused on expanding our network to
every EHR, so that every provider and every patient can easily access the prescription savings that are available on every drug.
This expansion of our network reach is a huge step that will connect us to an additional 120 million patients, given the market
dominance of Epic and Cerner.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
OptimizeRx platform now reaches more than 675,000 prescribers directly within their existing digital workflows, simplifying communication
and improving transparency. The expansion represents an 11% growth for the nation&rsquo;s largest point-of-prescribe network,
which has traditionally been focused on the ambulatory care setting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;As
we start to approach 2021 planning with our clients, the increased need for access to point-of-care communication with affordability
tools for physicians and patients has never been so critical,&rdquo; said Will Febbo, CEO of OptimizeRx. &ldquo;This further expansion
into Epic and Cerner systems builds on previous integrations and gives us additional scale in the inpatient care setting. From
within provider workflow, we are able to provide information to support the necessary financial discussions between physicians
and patients when selecting treatment.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information on OptimizeRx, its products or other news, visit www.optimizerx.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
OptimizeRx</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OptimizeRx
Corporation (NASDAQ: OPRX) is a digital health company that facilitates communication at point-of-care among all stakeholders
in healthcare. Primarily focused on life science and payer clients, its suite of digital and mobile SaaS-based solutions enables
affordability, patient adherence and care management. OptimizeRx&rsquo;s network reaches more than 60% of U.S. ambulatory providers,
delivering therapeutic support on specialty medications and patient financial assistance directly within a provider&rsquo;s workflow
through leading electronic health platforms. OptimizeRx&rsquo;s fully integrated platform supports the real-time exchange of information,
improving provider knowledge and patient engagement, and ultimately leading to healthier outcomes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information, follow the company on&#8239;Twitter,&#8239;LinkedIn&#8239;or visit&#8239;www.optimizerx.com.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Important
Cautions Regarding Forward Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended,
and such as in section 21E of the Securities Act of 1934, as amended. These forward-looking statements should not be used to make
an investment decision. The words &lsquo;estimate,&rsquo; &lsquo;possible&rsquo; and &lsquo;seeking&rsquo; and similar expressions identify forward-looking statements,
which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any
forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently
subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ
materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties
to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition
and other material risks.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OptimizeRx&nbsp;Contact</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Doug
Baker, CFO</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel
(248) 651-6568 (x807)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dbaker@optimizerx.com&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Media
Relations Contact</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maira
Alejandra, Media Relations Manager</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel
(754) 245-7070</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">malejandra@optimizerx.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Relations Contact</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ron
Both, CMA&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel
(949) 432-7557&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">oprx@cma.team</FONT></P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !@ 9@# 2(  A$! Q$!_\0
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MJLVJ:]JECH^G0E@2!)>ZA/;VR,0I(#2C(!(S@USK5I)-MNR23;;[))._RO\
M>0;5%<?X3^(/@/QY%//X'\;^#_&<%J0+J?PGXFT;Q'%;%B0HGDTB\O$A)((
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MS623L+1117Z8>N%%)D\<#MGGU./3!Q]?YBEI)W ****8!7\>7_!VY\0;RP\
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MR^,-LGEZWJVF?&7X3:G<J KR:9IT?A3QCX?5G&"?L=Y?^(WA_N->2D8+'/\
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MGS_MU_\ 9-9?_5Y:Q7]Q5>AQ DLTJI))>PPFB22_W>'1)+UTUZW>I>(_BO\
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M]J7XFZQ>_!6$>*/'EC:V-KX$^)'A[PM9R1?VGXO\/:KX+N(-%\7Z-H4;-?\
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MIJ,ZMH_ASXV?#"VU34?!7C;P%XJNHVT6W\0VL=K-9ZL]K:O:^']2O]&U"?\
MT *_._\ X*U>"=*^('_!-']MWP[K$$4]JG[.WQ$\20"5 XAU7P3H\OC/0[Q
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M:W>+[,HI4YSI3C5I3G3J0=XSA)QE%^3BT_+JK75K-@FXM.+::V:=FOF?S_\
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M<_\ #)NG_P#ATOC1C\O^%AXK]E**Z/[2S%?\Q^,_\**O_P D5[:K_P _)_\
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910 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
